Table 4.
Risk of malignancy of FTI (random effects, I2 = 57%, symbol size reflects weight).
| Study | FTI | Malignant | ROM [95% CI | |
|---|---|---|---|---|
| Kamakshi et al. (82) | 29 | 3 | 10.34 [-1.36,22.04] |
|
| Elzein et al. (47) | 16 | 2 | 12.50 [-4.83,29.83] | |
| Thuillier et al. (71) | 62 | 10 | 16.1 [6.13,26.13] | |
| Bakhshayesh Karam et al. (81) | 18 | 3 | 16.67 [-2.18,35.52] | |
| Fujii et al. (36) | 18 | 3 | 16.67 [-2.18,35.52] | |
| Kim et al. (28) | 18 | 9 | 18..00 [6.24,29.76] | |
| Kim et al. (42) | 177 | 37 | 20.904.16,27.64] | |
| Achury et al. (44) | 23 | 5 | 21.74 [2.69,40.79] | |
| Agrawal et al. (52) | 41 | 9 | 21.95 [7.60,36.30] | |
| Abdel-Halim et al. (75) | 104 | 23 | 22.12 [3.08,31.16] | |
| Jamsek et al. (55) | 52 | 12 | 23.08 [0.01,36.13] | |
| Nishimori et al. (30) | 39 | 9 | 23.08 [8.01, 38.15] | |
| Stangierski et al. (49) | 82 | 19 | 23.17 [2.74, 33.60] | |
| Bonabi et al. (35) | 42 | 10 | 23.81 [9.05, 38.57] | |
| Larg et al. (77) | 29 | 7 | 24.14 [6.27, 42.01] | |
| Kim et al. (56) | 200 | 49 | 24.50 [7.64, 31.36] | |
| Makis et al. (67) | 57 | 14 | 24.56 [11.70, 37.42] | |
| Lee et al. (38) | 16 | 4 | 25.0 [0.50, 49.50] | |
| Pak et al. (69) | 238 | 62 | 26.05 [19.56, 32.54] | |
| Kumar et al. (76) | 19 | 5 | 26.3 [3-25, 49.39] | |
| Kim et al. (23) | 140 | 37 | 26.43 [17.92, 34.94] | |
| Brindle et al. (45) | 26 | 7 | 26.9 [6.97, 46.87] | |
| Vaish et al. (64) | 26 | 7 | 26.92 [6.97, 46.87] | |
| Lin et al. (78) | 70 | 19 | 27.14 [14.93, 39.35] | |
| Boeckmann et al. (34) | 103 | 28 | 27.18 [17.11, 37.25] | |
| Kim et al. (42) | 286 | 79 | 27.62 [21.52, 33.72] | |
| Trimboli et al. (83) | 75 | 21 | 28.00 [16.02, 39.98] | |
| Wong et al. (33) | 59 | 17 | 28.81 [15.11, 42.51] | |
| Demir et al. (60) | 32 | 10 | 31.25 [11.89, 50.61] | |
| Barrrio et al. (59) | 67 | 21 | 31.34 [17.93, 44.75] | |
| Sollini et al. (70) | 55 | 18 | 32.73 [17.62, 47.84] | |
| Bertagna et al. (41) | 211 | 72 | 34.12 [26.24, 42.00] | |
| Sager et al. (74) | 126 | 43 | 34.13 [23.94, 44.32] | |
| Oven et al. (79) | 40 | 14 | 35.00 [16.67, 53.33] | |
| Yaylali et al. (50) | 20 | 7 | 35.00 [9.07, 60.93] | |
| Pattison et al. (73) | 131 | 47 | 35.88 [15.63, 46.13] | |
| Chung et al. (72) | 1342 | 496 | 36.96 [33.71, 40.21] | |
| Hsiao et al. (27) | 45 | 17 | 37.78 [19.83, 55.73] | |
| Pagano et al. (31) | 36 | 14 | 38.89 [18.53, 59.25] | |
| Flukes et al. (61) | 53 | 21 | 39.62 [22.67, 56.57] | |
| Kung et al. (24) | 15 | 6 | 40.00 [7-99, 72.01] | |
| Prichard et al. (32) | 20 | 8 | 40 [12.29, 67.71] | |
| Pampaloni (39) | 32 | 13 | 40.63 [18.54, 62.72] | |
| Sencan Eren et al. (63) | 49 | 20 | 40.82 [22.93, 58.71] | |
| Chun et al. (53) | 36 | 15 | 41.67 [20.58, 62.76] | |
| Nilsson et al. (29) | 26 | 11 | 42.31 [17.30, 67.32] | |
| Gavriel et al. (54) | 48 | 21 | 43.75 [25.03, 62.47] | |
| Adas et al. (51) | 25 | 11 | 44.00 [17.99, 70.01] | |
| Czepcyński et al. (26) | 20 | 9 | 45.00 [15.60, 74.40] | |
| Choi et al. (46) | 171 | 78 | 45.61 [35.50, 55.72] | |
| Yoon et al. (58) | 87 | 40 | 45.98 [31.73, 60.23] | |
| Ozderya et al. (68) | 76 | 35 | 46.05 [30.80, 61.30] | |
| Hassan et al. (62) | 50 | 24 | 48.00 [28.79, 67.21] | |
| Kao et al. (37) | 6 | 3 | 50.00 [-6.58, 106.58] | |
| Li et al. (66) | 20 | 10 | 50.00 [19.01, 80.99] | |
| Zhai et al. (25) | 96 | 48 | 50.00 [35.85, 64.15] | |
| Shi et al. (80) | 87 | 52 | 59.77 [43.52, 76.02] | |
| Marques et al. (48) | 23 | 14 | 60.87 [28.98, 92.76] | |
| Sharma et al. (57) | 9 | 6 | 66.67 [13.32, 120.02] | |
| Summary | 30.75 | 28.06, 33.43 |
ROM, Risk of Malignancy; FTI, Focal Thyroid Incidentaloma.